Haematuria in a young patient with severe haemophilia and inhibitor presence receiving prophylactic treatment with recombinant factor VIIa

被引：0
|
作者：
Economou, Marina [1 ]
Papadopoulou, Eleni [1 ]
Vagianou, Isidora [1 ]
Farmaki, Evaggelia [1 ]
Gompakis, Nikolaos [1 ]
Athanassiou-Metaxa, Miranda [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Dept Pediat 1, Hippokration Gen Hosp, GR-54006 Thessaloniki, Greece
来源：
BLOOD COAGULATION & FIBRINOLYSIS | 2010年 / 21卷 / 06期
关键词：
D O I：
10.1097/MBC.0b013e32833c2b79
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：611 / 613
页数：3
相关论文
共 50 条
  • [21] Succesful control of bleeding with recombinant factor VIIa in a haemophilia patient with an Inhibitor undergoing transurtethral resection of the prostate
    Funding, E.
    Poulsen, L. H.
    HAEMOPHILIA, 2013, 19 : 15 - 15
  • [22] Short-course use of recombinant factor VIIa in a haemophilia patient with inhibitor undergoing cataract surgeries
    Pekçelen, Y
    Yavuz, AS
    Namli, S
    Gücükoglu, A
    BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 (06) : 445 - 446
  • [23] Acquired factor V inhibitor in a patient with severe haematuria
    Azevedo, O.
    Oueiros, F.
    Torres, E.
    Cotter, J.
    Queiros, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 444 - 444
  • [24] Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
    Lin, Yulia
    Stanworth, Simon
    Birchall, Janet
    Doree, Carolyn
    Hyde, Chris
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (02):
  • [25] Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
    Stanworth, S. J.
    Birchall, J.
    Doree, C. J.
    Hyde, C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02):
  • [26] The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: A multicentre study
    Hay, CRM
    Negrier, C
    Ludlam, CA
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (06) : 1463 - 1467
  • [27] Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
    Simpson, Ewurabena
    Lin, Yulia
    Stanworth, Simon
    Birchall, Janet
    Doree, Carolyn
    Hyde, Chris
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (03):
  • [28] The evidence behind inhibitor treatment with recombinant factor VIIa
    Ludlam, CA
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2002, 32 : 13 - 18
  • [29] Does prophylactic factor replacement prevent asymptomatic microscopic haematuria in adult people with severe haemophilia?
    Teoman, S.
    Ar, M. C.
    Cengiz, M.
    Kececi, D.
    Eskazan, A. E.
    Salihoglu, A.
    Gulturk, E.
    Aydin, S. O.
    Baslar, Z.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 929 - 929
  • [30] RECOMBINANT FACTOR VIIA AND ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE GIVEN AS SEQUENTIAL THERAPY TO A PATIENT WITH SEVERE HAEMOPHILIA A AND INHIBITOR DEVELOPMENT PRESENTING WITH A LIFE THREATENING HEMORRHAGE
    Economou, M.
    Tzavella, D.
    Dragoumi, P.
    Tsatra, I.
    Tsikopoulos, G.
    Stefanidis, C.
    Gompakis, N.
    Athanassiou-Metaxa, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 756 - 757
12345